PBYI AS OF 12/31/2013

Company

PUMA BIOTECHNOLOGY, INC.

Filed

January 10, 2014

Accession Number

0000080255-14-000002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →